Altimmune, Inc. Income Statement
ALT|10 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 10 fiscal years. All figures from audited SEC 10-K filings.
Altimmune, Inc. reported $41,000 in revenue and $88M in net loss for FY2025. Revenue has declined at a 36.0% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.0K | $426.0K | -$68.0K | $4.4M | $8.2M | $5.8M | $10.3M | $10.7M | $3.2M | $21.0M |
| SG&A Expense | $28.1M | $18.1M | $17.1M | $15.4M | $13.2M | $8.5M | $9.8M | $8.5M | $7.1M | $18.0M |
| R&D Expense | $66.4M | $65.8M | $70.5M | $74.5M | $49.8M | $17.8M | $18.5M | $18.4M | $7.2M | $20.9M |
| Operating Income | -$94.5M | -$95.9M | -$87.7M | -$96.9M | -$54.8M | -$21.5M | -$42.8M | -$52.0M | -$11.1M | -$23.6M |
| Interest Expense | - | - | $8.0K | $5.0K | $9.4K | $2.2K | $297.1K | $162.1K | $38.5K | $5.9M |
| Income Tax | -$681.0K | - | -$197.0K | -$197.0K | -$5.4M | -$58.5K | -$6.1M | -$5.6M | $0 | - |
| Net Income | -$88.1M | -$88.4M | -$84.7M | -$97.1M | -$49.0M | -$20.5M | -$39.2M | -$46.4M | -$11.1M | -$34.8M |
| EPS (Basic) | -$1.34 | -$1.66 | -$1.81 | -$2.35 | -$1.91 | - | - | - | - | - |
| EPS (Diluted) | -$1.34 | -$1.66 | -$1.81 | -$2.35 | -$1.91 | -$1.60 | -$15.16 | -$118.91 | -$1.66 | -$1.08 |
| Shares Outstanding | 72.4M | 70.7M | 49.2M | 41.0M | 37.1M | 15.3M | 9.1M | 608.5K | 6.9M | 46.2M |
| Operating Margin | -230461.0% | -22518.5% | 129029.4% | -2197.6% | -669.5% | -370.0% | -414.6% | -484.7% | -342.7% | -112.2% |
| Profit Margin | -214861.0% | -20762.2% | 124577.9% | -2201.6% | -599.2% | -353.7% | -379.2% | -432.3% | -342.6% | -166.0% |